Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sotyktu
Pharma
Trial results enhance BMS bid for Sotyktu in psoriatic arthritis
At the American Academy of Dermatology's annual meeting, BMS revealed data from one of two successful phase 3 trials of Sotyktu in psoriatic arthritis.
Kevin Dunleavy
Mar 10, 2025 8:38am
JPM25: Takeda touts 6 pipeline assets with big sales potential
Jan 15, 2025 3:17pm
Sotyktu has excelled in 2 psoriatic arthritis trials, BMS says
Dec 23, 2024 11:25am
CEO says BMS can handle impact of IRA price negotiation
Jul 26, 2024 11:36am
Bristol Myers’ top challenges, as seen by analysts
Jul 12, 2024 12:00pm
The top 10 pharma drug ad spenders for 2023
Jun 3, 2024 3:00am
